← Open Payments lookup

CRYSTAL KIZARR: Open Payments

NPI 1053661181 · DUNCAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 63 payments from 28 companies in 2025. Trend: 2023 $1,126 · 2024 $1,163 · 2025 $1,519

Food & beverage: $1,321Education: $198
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$285
Janssen Biotech, Inc.6$199
Incyte Corporation3$146
Merck Sharp & Dohme LLC7$136
Alexion Pharmaceuticals, Inc.2$64
GENZYME CORPORATION2$63
PFIZER INC.2$51
Lilly USA, LLC3$49
AstraZeneca Pharmaceuticals LP2$46
KYOWA KIRIN, INC.2$44

Products named: RYBREVANT, KISQALI, KEYTRUDA, LUTATHERA, ULTOMIRIS, SARCLISA, SCEMBLIX, VERZENIO.

Industry payments across OK — which companies pay providers there.